Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Histologic Findings in Parkinson's Disease

Clinical Features and Diagnosis

  • The American College of Radiology identifies bradykinesia, rigidity, and postural instability as cardinal features of Parkinson's disease, which typically manifests after approximately 40-50% of dopaminergic neurons in the substantia nigra have been lost 1
  • The patient's age is consistent with the typical peak onset of Parkinson's disease between 60-70 years 1

Histopathological Findings

  • Parkinson's disease is classified as a synucleinopathy, characterized by abnormal cytoplasmic inclusions of alpha-synuclein 2
  • The American College of Radiology distinguishes Parkinson's disease from other parkinsonian syndromes based on their histopathology, with Parkinson's disease showing alpha-synuclein accumulation in neurons 4, 2
  • These intracellular alpha-synuclein inclusions, known as Lewy bodies, are the hallmark histopathological finding in Parkinson's disease 3

Differential Diagnosis

  • Multiple System Atrophy (MSA) differs from Parkinson's disease in that alpha-synuclein accumulates primarily in oligodendroglia rather than neurons 4, 2
  • Alzheimer's disease is characterized by extracellular amyloid beta plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau 3

Clinical Pearls

  • Lewy body disease can be classified into different stages based on the distribution of alpha-synuclein pathology, with neocortical involvement typically associated with cognitive impairment 3
  • The diagnosis of Parkinson's disease can be challenging based on clinical features alone, and imaging studies like I-123 ioflupane SPECT/CT can help differentiate Parkinson's disease from essential tremor 4
  • While Parkinson's disease and MSA both involve alpha-synuclein accumulation, their cellular distribution patterns differ, with Parkinson's disease affecting neurons and MSA affecting oligodendroglia 4, 2